Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825634 | Clinical Therapeutics | 2013 | 10 Pages |
Abstract
Age and serum creatinine level can be used at the bedside to determine the initial doses of ceftazidime. These Monte Carlo simulations highlight the need of a reappraisal of ceftazidime's use in burn patients. Doses between 3 and 16 g/d are proposed, taking into account the pathogens' MICs. However, for sepsis caused by a pathogen with an MIC â¥8 mg/L, an insufficient percentage of burn patients will reach the therapeutic target with the recommended dosages.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jean-Marie MD, PhD, Bernard MD, PhD, François MD, Stéphanie MD, Thierry MD, David PharmD, Olivier MD, PhD, Sylvie PharmD, MD, PhD,